4P-Pharma
4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
4P-Pharma is active in the biotechnology, clinical trials, health care space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2014.
Within the biotechnology, clinical trials, health care space, the company focuses on its core offering rather than a broad product line.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Undisclosed.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $15M.
| Sector | Biotechnology, Clinical Trials, Health Care |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | FR |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | undisclosed |
| Total funding | $15,000,000 |
Website: 4p-pharma.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account